United States Pimozide Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Pimozide Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Pimozide Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Pimozide Overall Market Size
2.1 United States Pimozide Market Size: 2021 VS 2027
2.2 United States Pimozide Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Pimozide Sales: 2016-2027
3 Company Landscape
3.1 Top Pimozide Players in United States Market
3.2 Top United States Pimozide Companies Ranked by Revenue
3.3 United States Pimozide Revenue by Companies
3.4 United States Pimozide Sales by Companies
3.5 United States Pimozide Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pimozide Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Pimozide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pimozide Players in United States Market
3.8.1 List of Tier 1 Pimozide Companies in United States
3.8.2 List of Tier 2 and Tier 3 Pimozide Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Pimozide Market Size Markets, 2021 & 2027
4.1.2 1Mg
4.1.3 2Mg
4.1.4 4Mg
4.2 By Type - United States Pimozide Revenue & Forecasts
4.2.1 By Type - United States Pimozide Revenue, 2016-2021
4.2.2 By Type - United States Pimozide Revenue, 2022-2027
4.2.3 By Type - United States Pimozide Revenue Market Share, 2016-2027
4.3 By Type - United States Pimozide Sales & Forecasts
4.3.1 By Type - United States Pimozide Sales, 2016-2021
4.3.2 By Type - United States Pimozide Sales, 2022-2027
4.3.3 By Type - United States Pimozide Sales Market Share, 2016-2027
4.4 By Type - United States Pimozide Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Pimozide Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - United States Pimozide Revenue & Forecasts
5.2.1 By Application - United States Pimozide Revenue, 2016-2021
5.2.2 By Application - United States Pimozide Revenue, 2022-2027
5.2.3 By Application - United States Pimozide Revenue Market Share, 2016-2027
5.3 By Application - United States Pimozide Sales & Forecasts
5.3.1 By Application - United States Pimozide Sales, 2016-2021
5.3.2 By Application - United States Pimozide Sales, 2022-2027
5.3.3 By Application - United States Pimozide Sales Market Share, 2016-2027
5.4 By Application - United States Pimozide Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Pimozide Sales and Revenue in United States Market (2016-2021)
6.1.4 Teva Pimozide Product Description
6.1.5 Teva Recent Developments
6.2 Par Pharmaceutical
6.2.1 Par Pharmaceutical Corporation Information
6.2.2 Par Pharmaceutical Overview
6.2.3 Par Pharmaceutical Pimozide Sales and Revenue in United States Market (2016-2021)
6.2.4 Par Pharmaceutical Pimozide Product Description
6.2.5 Par Pharmaceutical Recent Developments
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Overview
6.3.3 Johnson & Johnson Pimozide Sales and Revenue in United States Market (2016-2021)
6.3.4 Johnson & Johnson Pimozide Product Description
6.3.5 Johnson & Johnson Recent Developments
6.4 Eumedica
6.4.1 Eumedica Corporation Information
6.4.2 Eumedica Overview
6.4.3 Eumedica Pimozide Sales and Revenue in United States Market (2016-2021)
6.4.4 Eumedica Pimozide Product Description
6.4.5 Eumedica Recent Developments
6.5 Pharmascience
6.5.1 Pharmascience Corporation Information
6.5.2 Pharmascience Overview
6.5.3 Pharmascience Pimozide Sales and Revenue in United States Market (2016-2021)
6.5.4 Pharmascience Pimozide Product Description
6.5.5 Pharmascience Recent Developments
6.6 Domina Pharmaceuticals
6.6.1 Domina Pharmaceuticals Corporation Information
6.6.2 Domina Pharmaceuticals Overview
6.6.3 Domina Pharmaceuticals Pimozide Sales and Revenue in United States Market (2016-2021)
6.6.4 Domina Pharmaceuticals Pimozide Product Description
6.6.5 Domina Pharmaceuticals Recent Developments
6.7 Aa Pharma
6.7.1 Aa Pharma Corporation Information
6.7.2 Aa Pharma Overview
6.7.3 Aa Pharma Pimozide Sales and Revenue in United States Market (2016-2021)
6.7.4 Aa Pharma Pimozide Product Description
6.7.5 Aa Pharma Recent Developments
7 United States Pimozide Production Capacity, Analysis
7.1 United States Pimozide Production Capacity, 2016-2027
7.2 Pimozide Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Pimozide Supply Chain Analysis
9.1 Pimozide Industry Value Chain
9.2 Pimozide Upstream Market
9.3 Pimozide Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Pimozide Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Pimozide in United States Market
Table 2. Top Pimozide Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Pimozide Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Pimozide Revenue Share by Companies, 2016-2021
Table 5. United States Pimozide Sales by Companies, (K Units), 2016-2021
Table 6. United States Pimozide Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pimozide Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Pimozide Product Type
Table 9. List of Tier 1 Pimozide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pimozide Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of 1Mg
Table 12. Major Manufacturers of 2Mg
Table 13. By Type - United States Pimozide Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Pimozide Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Pimozide Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Pimozide Sales (K Units), 2016-2021
Table 17. By Type - United States Pimozide Sales (K Units), 2022-2027
Table 18. By Application - United States Pimozide Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Pimozide Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Pimozide Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Pimozide Sales (K Units), 2016-2021
Table 22. By Application - United States Pimozide Sales (K Units), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Teva Pimozide Product
Table 27. Teva Recent Developments
Table 28. Par Pharmaceutical Corporation Information
Table 29. Par Pharmaceutical Description and Major Businesses
Table 30. Par Pharmaceutical Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Par Pharmaceutical Pimozide Product
Table 32. Par Pharmaceutical Recent Developments
Table 33. Johnson & Johnson Corporation Information
Table 34. Johnson & Johnson Description and Major Businesses
Table 35. Johnson & Johnson Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Johnson & Johnson Pimozide Product
Table 37. Johnson & Johnson Recent Developments
Table 38. Eumedica Corporation Information
Table 39. Eumedica Description and Major Businesses
Table 40. Eumedica Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Eumedica Pimozide Product
Table 42. Eumedica Recent Developments
Table 43. Pharmascience Corporation Information
Table 44. Pharmascience Description and Major Businesses
Table 45. Pharmascience Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Pharmascience Pimozide Product
Table 47. Pharmascience Recent Developments
Table 48. Domina Pharmaceuticals Corporation Information
Table 49. Domina Pharmaceuticals Description and Major Businesses
Table 50. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Domina Pharmaceuticals Pimozide Product
Table 52. Domina Pharmaceuticals Recent Developments
Table 53. Aa Pharma Corporation Information
Table 54. Aa Pharma Description and Major Businesses
Table 55. Aa Pharma Pimozide Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Aa Pharma Pimozide Product
Table 57. Aa Pharma Recent Developments
Table 58. Pimozide Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 59. United States Pimozide Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Pimozide Market Opportunities & Trends in United States Market
Table 61. Pimozide Market Drivers in United States Market
Table 62. Pimozide Market Restraints in United States Market
Table 63. Pimozide Raw Materials
Table 64. Pimozide Raw Materials Suppliers in United States Market
Table 65. Typical Pimozide Downstream
Table 66. Pimozide Downstream Clients in United States Market
Table 67. Pimozide Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Pimozide Product Picture
Figure 2. Pimozide Segment by Type
Figure 3. Pimozide Segment by Application
Figure 4. United States Pimozide Market Overview: 2020
Figure 5. United States Pimozide Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Pimozide Revenue, 2016-2027 (US$, Mn)
Figure 7. Pimozide Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pimozide Revenue in 2020
Figure 9. 1Mg Product Picture
Figure 10. 2Mg Product Picture
Figure 11. 4Mg Product Picture
Figure 12. By Type - United States Pimozide Sales Market Share, 2016-2027
Figure 13. By Type - United States Pimozide Revenue Market Share, 2016-2027
Figure 14. By Type - United States Pimozide Price (USD/Unit), 2016-2027
Figure 15. Hospitals
Figure 16. Drugstores
Figure 17. Others
Figure 18. By Application - United States Pimozide Sales Market Share, 2016-2027
Figure 19. By Application - United States Pimozide Revenue Market Share, 2016-2027
Figure 20. By Application - United States Pimozide Price (USD/Unit), 2016-2027
Figure 21. Teva Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Par Pharmaceutical Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Johnson & Johnson Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Eumedica Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Pharmascience Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Domina Pharmaceuticals Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Aa Pharma Pimozide Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. United States Pimozide Production Capacity (K Units), 2016-2027
Figure 29. Pimozide Industry Value Chain
Figure 30. Marketing Channels